Remitting–relapsing multiple sclerosis patient refractory to conventional treatments and bone marrow transplantation who responded to natalizumab

Bone marrow transplantation (BMT) was introduced as a treatment option 15 years ago for severe, drug-resistant multiple sclerosis (MS). Up until now, BMT has been undertaken in relatively few patients worldwide, with moderate success, and recent studies suggest that patients with early, highly aggre...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Mouzaki, Athanasia, Koutsokera, Maria, Dervilli, Zoe, Rodi, Maria, Kalavrizioti, Dimitra, Dimisianos, Nikolaos, Matsoukas, Ioannis, Papathanasopoulos, Panagiotis
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2010
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2962327/
https://ncbi.nlm.nih.gov/pubmed/21042570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S13648
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia